AU
UK
CA
US
IND
NZ
Last update at 2026-06-18T13:30:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Income before tax | -29.66862M | -3.13230M | -2.24015M | -2.98900M | -3.17660M |
| Minority interest | - | - | - | - | - |
| Net income | -29.66862M | -3.13230M | -2.24022M | -2.99140M | -3.18007M |
| Selling general administrative | 2.31M | 1.73M | 2.63M | 2.68M | 3.26M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 0.50M | 0.85M | 0.78M | 0.22M | 0.25M |
| Reconciled depreciation | - | - | - | - | - |
| Ebit | -2.41571M | -1.28174M | -1.85406M | -2.46278M | -3.00839M |
| Ebitda | -2.40571M | -0.11674M | - | - | - |
| Depreciation and amortization | - | - | - | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | -2.10143M | -1.29438M | -1.85406M | -2.46278M | -3.00839M |
| Other operating expenses | - | - | - | - | - |
| Interest expense | 27.26M | 3.02M | 0.00000M | 0.00000M | 0.00000M |
| Tax provision | 0.00273M | 0.00000M | - | - | - |
| Interest income | - | - | - | - | - |
| Net interest income | -27.26291M | -3.01555M | - | - | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.00273M | - | 0.00007M | 0.00240M | 0.00346M |
| Total revenue | 1.98M | 2.38M | 2.24M | 1.88M | 1.09M |
| Total operating expenses | 4.08M | 3.67M | 4.09M | 4.34M | 4.10M |
| Cost of revenue | 1.48M | 1.53M | 1.46M | 1.66M | 0.85M |
| Total other income expense net | - | - | -0.38609M | -0.52622M | -0.16822M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -29.67135M | -3.13230M | -2.24022M | -2.99140M | -3.18007M |
| Net income applicable to common shares | -29.66862M | -3.13230M | -2.24022M | -2.99140M | -3.18007M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Total assets | 5.65M | 5.31M | 4.19M | 5.13M | 6.22M |
| Intangible assets | 3.22M | 2.49M | 1.72M | 1.63M | 1.58M |
| Earning assets | - | - | - | - | - |
| Other current assets | - | - | - | 0.86M | 1.61M |
| Total liab | 5.17M | 5.22M | 3.09M | 3.49M | 3.86M |
| Total stockholder equity | 0.48M | 0.09M | 1.09M | 1.64M | 2.36M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 0.24M | 0.24M | 0.24M | 0.24M | 0.24M |
| Common stock | 0.35M | 0.16M | 0.13M | 0.11M | 0.09M |
| Capital stock | 0.36M | 0.16M | - | - | - |
| Retained earnings | -79.39855M | -49.72992M | -46.59763M | -44.35741M | -41.36601M |
| Other liab | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M |
| Good will | - | - | - | - | - |
| Other assets | - | - | - | - | - |
| Cash | 0.52M | 0.11M | 0.36M | 1.09M | 1.35M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 4.93M | 4.97M | 2.85M | 3.25M | 3.62M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 2.40M | 2.68M | - | - | - |
| Short term debt | - | - | - | 2.03M | 2.30M |
| Short long term debt | 2.93M | 2.79M | - | 2.03M | 2.30M |
| Short long term debt total | - | - | - | - | - |
| Other stockholder equity | -0.40218M | -0.40218M | -0.40218M | -0.40218M | -0.40359M |
| Property plant equipment | 0.80M | 0.80M | 0.80M | 0.80M | 0.74M |
| Total current assets | 1.63M | 1.33M | 1.67M | 2.70M | 3.91M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | -2.74182M | -3.08787M | -0.62676M | 0.01M | 0.78M |
| Short term investments | - | - | - | - | - |
| Net receivables | 0.94M | 1.05M | 0.95M | 0.44M | 0.54M |
| Long term debt | - | - | - | - | - |
| Inventory | 0.16M | 0.17M | 0.25M | 0.32M | 0.41M |
| Accounts payable | 1.70M | 1.25M | 1.03M | 0.81M | 0.72M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 0.73M | 0.68M | - | - | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 4.03M | 3.98M | - | - | - |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Investments | 0.05M | -0.11638M | - | - | - |
| Change to liabilities | 0.45M | 0.22M | 0.22M | -0.00109M | -0.02007M |
| Total cashflows from investing activities | 0.05M | -0.11638M | -0.09030M | -0.11464M | -0.32168M |
| Net borrowings | 2.06M | 0.69M | 0.68M | 0.99M | 1.87M |
| Total cash from financing activities | 2.06M | 0.99M | 0.68M | 1.41M | 3.93M |
| Change to operating activities | -0.28953M | 2.67M | 0.19M | 0.20M | 0.65M |
| Net income | -29.66862M | -3.13230M | -2.24022M | -2.99140M | -3.18007M |
| Change in cash | 0.71M | -0.24442M | -0.73000M | -0.26310M | 0.72M |
| Begin period cash flow | -0.18567M | 0.36M | - | - | - |
| End period cash flow | 0.52M | -0.18567M | 0.36M | - | - |
| Total cash from operating activities | -1.40497M | -1.11467M | -1.32295M | -1.55892M | -2.88134M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | - | - | - | 0.75M | 0.75M |
| Other cashflows from investing activities | - | - | - | -0.04974M | -0.01775M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | 0.00596M | -0.07828M | 0.07M | -0.00742M | -0.64575M |
| Change to account receivables | 0.47M | -0.27037M | -0.51189M | 0.10M | -0.41184M |
| Sale purchase of stock | - | - | - | 0.42M | 2.14M |
| Other cashflows from financing activities | - | - | - | - | -0.07750M |
| Change to netincome | 27.63M | -0.62898M | 0.20M | 0.39M | 0.72M |
| Capital expenditures | 0.00000M | 0.12M | 0.07M | 0.06M | 0.48M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 0.64M | 2.55M | - | - | - |
| Stock based compensation | - | 0.03M | - | - | - |
| Other non cash items | 26.67M | 0.45M | - | - | - |
| Free cash flow | -1.40497M | -1.23105M | - | - | - |
Sector: Healthcare Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DECN Decision Diagnostics |
- -% | 0.0001 | - | - | 0.02 | 2.72 | 1.44 | -1.4859 |
| ALBHF Alibaba Health Information Technology Limited |
- -% | 0.42 | 36.00 | 19.01 | 0.36 | 3.63 | 1.73 | 25.72 |
| RADLY Raia Drogasil SA ADR |
0.06 1.83% | 3.33 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
| ALBBY Alibaba Health Information Technology Limited |
- -% | 8.88 | 34.43 | 19.84 | 0.29 | 3.79 | 1.73 | 25.72 |
| SHPPF Shop Apotheke Europe N.V |
- -% | 64.80 | - | - | 2.80 | 2.28 | 1.70 | 78.78 |
Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.
2660 Townsgate Road, Westlake Village, CA, United States, 91361
| Name | Title | Year Born |
|---|---|---|
| Mr. Keith M. Berman | CEO, CFO, Sec. & Director | 1953 |
| Mr. Mark Krakauer | Head of Genstrip Private Label Sales Efforts | NA |
| Mr. Chris Knapp | Consultant | NA |
| Mr. Keith M. Berman | CEO, CFO, Secretary & Director | 1953 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...